Each scientific discovery gets us one step closer to our shared goal of ending the HIV epidemic. As a leader in HIV treatment and prevention, we’ll continue to build on our legacy and create innovative solutions to address the diverse needs of all people affected by HIV. Watch the video to learn more about our work.
Gilead Sciences
Biotechnology Research
Foster City, CA 637,912 followers
Creating Possible
Über uns
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines
- Website
-
http://www.gilead.com
External link for Gilead Sciences
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 10.001+ Mitarbeiter
- Hauptsitz
- Foster City, CA
- Typ
- Öffentliches Unternehmen
- Gegründet
- 1987
Standorte
Employees at Gilead Sciences
Aktualisierungen
-
“There are big gaps in treatment options for people with PBC. We need medicines and research into how to stop the itch, the fatigue, the brain fog and the fluid build-up.” Six years ago, registered nurse Maria Morais was diagnosed with a rare autoimmune liver disease called primary biliary cholangitis (PBC). Here, she describes how her journey from diagnosis to transplant and beyond transformed her into a patient advocate and peer counselor for others living with rare liver disease. https://gilead.inc/4cXvVd7
-
-
This year, we’re among 42 organizations being recognized by Seramount as a Leading Inclusion Index Company. The recognition highlights the connections we foster, the opportunities we create for underrepresented groups and the sense of belonging we cultivate. #SeramountInclusionIndex #GileadLife
-
Cancer can cause disruption for families and may especially impact children. “The Adventure Jar,” created by Gilead in partnership with the metastatic breast cancer community, showcases the perspective of one family navigating the challenges of a diagnosis and finding magic in time together. This book is part of our ongoing commitment to provide resources and support for people living with #MBC. Download a copy: https://gilead.inc/4e7IWSn
Order or Download the Book Today
-
Transformative medicines have the greatest impact when they reach the people who need them most. Here, Johanna Mercier, Chief Commercial Officer, shares how Gilead works to help remove barriers to care, improve health equity and increase access to life-changing therapies – all of which underscore our commitment to being a responsible company. #GileadForGood
-
#GileadNews: The U.S. FDA has granted accelerated approval for a new treatment for adults with primary biliary cholangitis (PBC). The treatment demonstrated significant and durable improvements in both liver disease markers and pruritus (chronic itch). https://gilead.inc/4e1wN1h
-
#GileadNews: Read the press release to learn more about our financial results from last quarter. https://gilead.inc/46GkIvL
-
At Gilead, everyone has an opportunity to lead and contribute. We know that diverse perspectives are one of our greatest strengths and those ideas fuel innovation. Learn more about our career opportunities. https://gilead.inc/3pCSeym #GileadLife
-
-
Summer Sitima, Gilead’s Commercial Operations Lead for South Africa, was motivated to pursue a medical career after losing her sister to HIV. Read how she’s helping to reach young people in greatest risk and need in her region of the world. https://gilead.inc/4dAerEj
-
-
Instead of focusing on the challenges, Jaymie’s stage 4 lung cancer diagnosis motivated her to do things she’d never done before. Inspired by stories like Jaymie’s, we’re working to transform the way cancer is treated for people with lung cancer. #WorldLungCancerDay
Verbundene Seiten
Ähnliche Seiten
Jobs durchsuchen
Aktie
GILD
NASDAQ
20 Minuten Verzögerung
$77.00
0.04 (0.052%)
- Öffnen Sie
- 77.21
- Niedrig
- 76.69
- Hoch
- 77.46
Daten von Refinitiv
Siehe mehr Informationen aufFinanzierung
Gilead Sciences
4 total rounds
![]()
Abingworth
Siehe mehr Informationen auf crunchbase
Letzte Runde
Eigenkapital nach dem IPO
Externer Crunchbase Link für die letzte Finanzierungsrunde
US$ 210.0M
Investoren